ARCHIVES

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

Bosnian Research Trying To Leave, Asks For More Calls

February 5, 1993

In Brief: New DRCCA Recruits: Cullen Will Be Greenwalds’s Deputy, Frelick To Become CCOP Project Officer

April 2, 1982

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

In Brief: James Carr Replaces Murphy As Interim Director of Organ Systems Coordinating Center In N.Y.

August 16, 1985

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show

November 28, 1986